1. Relapse patterns in patients with local and regional cutaneous melanoma.
   Faruk Tas, 0 CrossRef
2. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database
   Rosalynn R.Z. Conic et al, 2018, Journal of the American Academy of Dermatology CrossRef
3. Intratumoral 18F-FLT infusion in metabolic targeted radiotherapy
   Thititip Tippayamontri et al, 2019, EJNMMI Res CrossRef
4. Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis
   Bih-Rong Wei et al, 2019, Academic Pathology CrossRef
5. KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy
   Richard Partl et al, 2016, Support Care Cancer CrossRef
6. Detection of mitotic figures in thin melanomas—Immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain
   Karl Ottmann et al, 2015, Journal of the American Academy of Dermatology CrossRef
7. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes
   Michael E. Egger et al, 2016, Surgery CrossRef
8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors
   Rami N. Al-Rohil et al, 2016, Human Pathology CrossRef
9. null
   Diwakar Davar et al, 2017 CrossRef
10. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2
    Xige Chen et al, 2019, Biomedicine & Pharmacotherapy CrossRef
11. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations
    Yeongjoo Oh et al, 2019, Journal of the American Academy of Dermatology CrossRef
12. Contemporary Management of Early-Stage Melanoma
    Andrew J. Rosko et al, 2017, JAMA Facial Plast Surg CrossRef
13. Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients
    Shachar Laks et al, 2017, The American Surgeon CrossRef
14. Long non‐coding RNA LINC00665 promotes melanoma cell growth and migration via regulating the miR‐224‐5p/VMA21 axis
    Xiaonan Wang et al, 2020, Exp Dermatol CrossRef
15. Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma
    Daniel Kim et al, 2021, Arch Dermatol Res CrossRef
16. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.
    Faruk Tas, 0 CrossRef
17. Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
    Alessandra Buja et al, 2021, Front. Oncol. CrossRef
18. Automated Computational Detection, Quantitation, and Mapping of Mitosis in Whole-Slide Images for Clinically Actionable Surgical Pathology Decision Support
    Munish Puri et al, 2019, Journal of Pathology Informatics CrossRef
19. Evaluating the effect of detection modalities in the Danish clinical follow-up program of cutaneous melanoma—a retrospective cohort study
    Julie Tastesen Johannessen et al, 2022, Eur J Plast Surg CrossRef
20. Ulceration vs Mitosis in Cutaneous Melanoma: which is Superior for Predicting Prognosis Across Clinical Stages?
    Faruk Tas et al, 2022, Cancer Investigation CrossRef
21. Melanoma classification and management in the era of molecular medicine
    Sarem Rashid et al, 2022, Dermatologic Clinics CrossRef